Focus: Concentric Analgesics is a San Francisco-based biotechnology company focused on drug discovery and development, currently in early-stage clinical development with a concentrated pipeline targeting pain indications.
Profile data last refreshed 5h ago · AI intelligence enriched 2mo ago
Hot — 40 jobs added in 30d
Net +28 (40 new, 12 removed). Aggressive expansion phase.
Concentric is an early-stage, focused pain biotech with potential upside but significant execution risk and currently limited hiring, making it suitable only for investors in company-building and risk tolerance for uncertainty.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Concentric Analgesics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Concentric Analgesics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles